SIEMENS HEALTHCARE GMBH

Their core work

Siemens Healthcare (now Siemens Healthineers) is a major German medical technology company that develops advanced imaging systems, diagnostic platforms, and clinical AI solutions. In H2020 projects, they contribute industrial-grade expertise in X-ray detector technology, medical imaging hardware, and machine learning applied to clinical data. Their work spans from building next-generation X-ray detectors using perovskite materials to deploying AI for cancer diagnosis and cardiac disease detection. They serve as the bridge between deep engineering capability and clinical application, turning research prototypes into deployable medical devices.

What they specialise in

How they've shifted over time

In their early H2020 phase (2015–2018), Siemens Healthcare focused on hardware innovation — X-ray detector materials, breath-analysis sensors, and microfluidic screening devices. From 2019 onward, their focus shifted decisively toward AI-driven diagnostics and large-scale medical data integration, with projects targeting cancer imaging AI, cardiac disease detection, and multi-omics data platforms. The transition mirrors the broader industry move from building better imaging hardware to extracting clinical intelligence from the images those devices produce.

Siemens Healthcare is moving from being a medical device manufacturer into an AI-powered clinical decision support company, making them an ideal partner for projects combining imaging data with machine learning for diagnosis.

How they like to work

Siemens Healthcare overwhelmingly participates as a consortium partner (10 of 14 projects) rather than leading, which is typical for large industrial companies that contribute specific technical capability without taking on project management overhead. They coordinated only 2 projects, both focused on their core detector technology. With 161 unique partners across 27 countries, they operate as a high-connectivity hub — they don't stick to a small circle but engage broadly, making them an accessible partner for new consortia.

With 161 unique consortium partners spanning 27 countries, Siemens Healthcare has one of the broadest collaboration networks among medical technology companies in H2020. Their reach is pan-European with no strong geographic concentration, reflecting their role as a go-to industrial partner for health and imaging projects across the continent.

What sets them apart

Siemens Healthcare brings something rare to EU consortia: they are not just a research partner but a company that can actually manufacture and deploy the technology at scale. Unlike university labs or SMEs, they offer a direct path from research prototype to certified medical device. Their dual expertise in both imaging hardware (detectors, MRI, X-ray) and clinical AI software makes them uniquely positioned for projects that need the full chain from data acquisition to diagnostic intelligence.

Highlights from their portfolio

• DiCoMo
  Their largest funded project (EUR 1M) and one of only two they coordinated — developing next-generation hybrid-organic X-ray detectors, a core business area.
• PANCAIM
  Significant funding (EUR 612K) applying AI to pancreatic cancer using genomics and radiomics — represents their strategic shift toward clinical AI at scale.
• MAESTRIA
  Their most recent project (2021–2026) combining machine learning with cardiac imaging for early stroke and atrial fibrillation detection — signals their future direction.